Probiotics in Hospitalized Patients Study

Antibiotic Associated Diarrhea Clinical Trial

Official title:
Randomized Double-blind, Placebo-Controlled Trial Comparing the the Effect of Enhance Probiotic (EP, Go Live Rx,) Versus Placebo (Pl) on the Incidence of Clostridium Difficile Associated Diarrhea (CDAD) or Antibiotic-Associated Diarrhea (AAD)in Hospitalized Patients Initiated on Antibiotics

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to compare the effect of enhanced probiotic (EP, Live Rx) versus placebo (PL) on the incidence of Clostridium difficile associated diarrhea (CDAD) or antibiotic associated diarrhea (AAD) in hospitalized patients initiated on antibiotics.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)

Related Conditions & MeSH terms

Antibiotic Associated Diarrhea
Clostridium Difficile Associated Diarrhea
Diarrhea

Clinical Trial Details

NCT number	NCT01596153
Study type	Interventional
Source	South Shore Hospital
Contact
Status	Withdrawn
Phase	N/A

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01972932` - Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea	Phase 4
Completed	`NCT02765217` - Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children	Phase 4
Completed	`NCT01295918` - Probiotic Lactobacillus Reuteri to Prevent Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized Children	Phase 3
Completed	`NCT02871908` - Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial	Phase 4
Completed	`NCT01941160` - Effect of a Lacidofil® STRONG in Healthy Adults Taking Antibiotic Treatment	Phase 1/Phase 2